Squalene Market Overview:
According to the research report, the global squalene market was valued at USD 145.35 million in 2023 and is expected to reach USD 356.14 million by 2032, to grow at a CAGR of 10.5% during the forecast period.
Key Market Drivers:
- Rising demand in the cosmetics and personal care industry for natural emollients.
- Growing awareness of nutritional supplements with squalene derived from plant sources.
- Increasing use in pharmaceuticals for vaccines and drug delivery systems.
- Expansion of vegan and plant-based squalene to address sustainability concerns.
Download Free Sample PDF Copy of the Report:
https://www.polarismarketresearch.com/industry-analysis/squalene-market/request-for-sample
Key Companies in Squalene Market:
- Amyris, Inc
- ARISTA INDUSTRIES INC
- EMPRESA FIGUEIRENSE DE PESCA
- LDA
- Gracefruit Limited
- Kshimoto Special Liver Oil Co
- LTD
Squalene Market Scope
The market research scope for Squalene covers its applications in cosmetics, pharmaceuticals, and nutritional supplements. Extracted from plant-based sources (like olives) and sharks, squalene is a vital ingredient for skincare products, vaccines, and immune system support. Research emphasizes the growing shift toward plant-based and sustainable production methods due to ethical and environmental concerns. The cosmetics industry remains the largest consumer, driven by demand for natural emollients in anti-aging and moisturizing products. Analysts explore innovations in synthetic and bioengineered squalene to meet rising global demand. The pharmaceutical industry also propels market growth with the increasing use of squalene as an adjuvant in vaccines and drug delivery systems. Geographically, Europe and North America dominate due to consumer awareness and regulatory advancements. Market studies assess supply chain challenges, pricing trends, and sustainable sourcing opportunities, solidifying squalene’s role in health and personal care industries.
Squalene Market Segmentation:
The Squalene market is segmented based on source, application, and region. By source, the market is categorized into animal-based (shark liver oil), plant-based (olive oil, amaranth), and synthetic squalene. Plant-based squalene is gaining prominence due to ethical and environmental concerns. By application, the market includes cosmetics, pharmaceuticals, dietary supplements, and biotechnology. The cosmetics segment dominates, with squalene widely used in skincare products as a natural emollient. The pharmaceutical industry follows closely, utilizing squalene as an adjuvant in vaccines and drug formulations. Regionally, Europe and North America lead due to regulatory support and consumer demand for natural and sustainable products. Asia-Pacific is an emerging market with increasing use of squalene in cosmetics and supplements. Market segmentation focuses on technological advancements in bioengineered squalene and innovations in production processes, ensuring sustainable growth.
Squalene Market, Type Outlook (Revenue – USD Million, 2019-2032)
- Animal
- Shark Liver Oil
- Others
- Amaranth Oil
- Olive Oil
- Rice Bran Oil Plants
- Others
- Synthetic
Squalene Market, Application Outlook (Revenue – USD Million, 2019-2032)
- Pharmaceuticals
- Personal Care & Cosmetics
- Nutraceuticals
- Food & Beverages
- Others
Squalene Industry Developments:
In 2021, Rose Inc., a clean color cosmetics brand, was launched by Amyris, Inc.. The brand features non-comedogenic formulations made with patented bioengineered and sustainably derived ingredients, including squalene and hemi-squalene, showcasing Amyris’ commitment to innovation and sustainability.
In 2021, Amyris also introduced Terasana Clinical, a clean skincare brand. The products feature a proprietary formulation combining two of Amyris’ sustainably produced ingredients: squalene and cannabigerol (CBG), offering advanced solutions for skincare with clean and effective ingredients.
In 2020, Amyris announced plans to pursue licensing for the sale of plant-based squalene samples to pharmaceutical companies involved in developing adjuvants for vaccines such as influenza and COVID-19. Amyris also disclosed its intention to commence production of alternative squalene, with plans to commercialize and scale production by the fourth quarter, aiming to strengthen its position in the pharmaceutical and sustainable squalene markets.
The Squalene market report offers an in-depth analysis of market dynamics, including trends, sizes, patterns, and growth factors. It highlights critical developments and emerging trends to help stakeholders refine their strategies and strengthen market positioning. The report concludes with a detailed summary of key findings and the research methodologies employed. This comprehensive analysis serves as a valuable resource for businesses, investors, and stakeholders, enabling them to make informed decisions and drive sustainable growth.